Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
P. Ravi Kiran MBBS, MS (General Surgery), FRCS (England), FRCS (Glasgow), FACS, is currently appointed as Staff Surgeon and Section Head of Research in the Department of Colorectal Surgery at Cleveland Clinic. He is board-certified by the American College of Surgeons and is a Fellow of the Royal College of Surgeons of England and the Royal College of Surgeons of Glasgow.
He completed general surgical residency in New York and Connecticut, and fellowship training in colorectal surgery at the Cleveland Clinic. He completed medical school and general surgical training at Osmania Medical College, Hyderabad, India. He then underwent four years of advanced training in colorectal surgery in Oxford, Cambridge, Gloucester and Swindon in the United Kingdom before completing training in general surgery and colorectal surgery in the USA.
Clinical interests include surgery for inflammatory bowel disease including ileoanal pouch surgery, Redo pouch surgery, Koch pouch (continent ileostomy), laparoscopic surgery, surgery for colon and rectal cancer and complex reoperative abdominal and pelvic surgery.
Research interests include inflammatory bowel disease, outcomes studies, clinical trials and clinical databases. He is the author of numerous publications in peer-reviewed journals, several chapters for surgical text books and has presented at various national and international meetings pertaining to colon and rectal surgery.
Anorectal Disease, cancer and polyps of the colon and rectum, cancer of the colon, carcinoma of the colon, carcinoma of the rectum, carcinoma of the small bowel and large bowel, colon and rectal cancer, colon and rectal surgery, Colon Cancer, Colonoscopy, Colorectal Cancer, colorectal cancer research, colorectal surgery, Crohn's Disease, diverticiulitis pelvic pouch procedures for mucosal ulcerative colitis and familial adenomatous polyposis sphincter-saving operations, diverticular disease, diverticulitis, inflammatory bowel disease, laparoscopic colectomy, laparoscopic colon resection, laparoscopic colon surgery, laparoscopic colorectal surgery, Laparoscopic Surgery, pelvic pouch procedures for ulcerative colitis and familial polyposis, rectal cancer, Rectal Prolapse, reoperative surgery, Ulcerative Colitis
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/28/2012, Dr. Kiran has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.